Economics Hurdle Rate Pharmaceutical Valuation 
CFO News Room
JANUARY 18, 2023
Even though we live in an age where user platforms and hyper revenue growth can drive company valuations, that adage remains true. The last few years have been eventful for all companies, with the COVID crisis and ensuing economic shut down causing pain for companies, with recovery coming in 2021, as the global economy opened up again.
Musings on Markets
FEBRUARY 27, 2022
Even though we live in an age where user platforms and hyper revenue growth can drive company valuations, that adage remains true. The last few years have been eventful for all companies, with the COVID crisis and ensuing economic shut down causing pain for companies, with recovery coming in 2021, as the global economy opened up again.
Expert insights. Personalized for you.
130 
Let's personalize your content